News
Truist analysts raised their price target on Amazon (NASDAQ:AMZN) shares to $250 from $226 in a note Wednesday, maintaining a ...
Investing.com -- Bernstein analysts remain bullish on Starbucks (NASDAQ: SBUX ), stating the stock could double from its post ...
Investing.com -- Regeneron Pharmaceuticals (NASDAQ: REGN) stock rose 2.8% after the U.S. Food and Drug Administration granted accelerated approval for the company’s blood cancer therapy Lynozyfic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results